In this study the authors address the efficacy and safety of Gamma Knife surgery (GKS) in patients with adrenocorticotropic hormone–secreting pituitary adenomas.
A review of data collected from a prospective GKS database between January 1990 and March 2005 was performed in patients with Cushing's disease. All but one patient underwent resection for a pituitary tumor, without achieving remission. Successful endocrine outcome after GKS was defined as a normal 24-hour urinary free cortisol (UFC) concentration posttreatment after a minimum of 1 year of follow up. Patient records were also evaluated for changes in tumor volume, development of new hormone deficiencies, visual acuity, cranial nerve neuropathies, and radiation-induced imaging changes. Ninety evaluable patients had undergone GKS, with a mean endocrine follow-up duration of 45 months (range 12–132 months). The mean dose to the tumor margin was 23 Gy (median 25 Gy).
Normal 24-hour UFC levels were achieved in 49 patients (54%), with an average time of 13 months after treatment (range 2–67 months). In the 49 patients in whom a tumor was visible on the planning magnetic resonance (MR) image, a decrease in tumor size occurred in 39 (80%), in seven patients there was no change in size, and tumor growth occurred in three patients. Ten patients (20%) experienced a relapse of Cushing's disease after initial remission; the mean time to recurrence was 27 months (range 6–60 months). Seven of these patients underwent repeated GKS, with three patients achieving a second remission. New hormone deficiencies developed in 20 patients (22%), with hypothyroidism being the most common endocrinopathy after GKS. Five patients experienced new visual deficits or third, fourth, or sixth cranial nerve deficits; two of these patients had undergone prior conventional fractionated radiation therapy, and four of them had received previous GKS. Radiation-induced changes were observed on MR images in three patients; one had symptoms attributable to these changes.
Gamma Knife surgery is an effective treatment for persistent Cushing's disease. Adenomas with cavernous sinus invasion that are not amenable to resection are treatable with the Gamma Knife. A second GKS treatment appears to increase the risk of cranial nerve damage. These results demonstrate the value of combining two neurosurgical treatment modalities—microsurgical resection and GKS—in the management of pituitary adenomas.
ArnottRD,,PestellRG,,McKelviePA,,HendersonJK,,McNeillPM,&AlfordFP:A critical evaluation of transsphenoidal pituitary surgery for the treatment of Cushing's disease: prediction of outcome.Acta Endocrinol123:423- - - - - -430,1990
BacklundEO:Stereotactic radiosurgery in intracranial tumors and vascular malformations.Adv Tech Stand Neurosurg6:1- - - - - -37,1979
BeckerG,,KocherM,,KortmannRD,,PaulsenF,,JeremicB,&MullerRP,et al.:Radiation therapy in the multimodal treatment approach of pituitary adenoma.Strahlenther Onkol178:173- - - - - -186,2002
BradaM,,FordD,,AshleyS,,BlissJM,,CrowleyS,&MasonM,et al.:Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma.Br Med J304:1343- - - - - -1346,1992
ChandlerWF,,SchteingartDE,,LloydRV,,McKeeverPE,&Ibarra-PerezG:Surgical treatment of Cushing's disease.J Neurosurg66:204- - - - - -212,1987
ChenJC,,GiannottaSL,,YuC,,PetrovichZ,,LevyML,&ApuzzoML:Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications.开云体育app官方网站下载入口48:1022- - - - - -1032,2001
ConstineLS,,WoolfPD,,CannD,,MickG,,McCormickK,&RaubertasRF,et al.:下丘脑垂体dysfunction after radiation for brain tumors.N Engl J Med328:87- - - - - -94,1993
DegerbladM,,RahnT,,BergstrandG,&ThorenM:Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease.Acta Endocrinol112:310- - - - - -314,1986
DickermanRD,&OldfieldEH:Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.J Neurosurg97:1343- - - - - -1349,2002
DoppmanJL,,NiemanLK,,ChangR,,YanovskiJ,,CutlerGBJr,&ChrousosGP,et al.:Selective venous sampling from the cavernous sinuses is not a more reliable technique than sampling from the inferior petrosal sinuses in Cushing's syndrome.J Clin Endocrinol Metab80:2485- - - - - -2489,1995
EstradaJ,,BoronatM,,MiegloM,,MagallonR,,MillanI,&DiezS,et al.:The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.N Engl J Med336:172- - - - - -177,1997
EstradaJ,,Garcia-UriaJ,,LamasC,,AlfaroJ,,LucasT,&DiezS,et al.:The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease.J Clin Endocrinol Metab86:5695- - - - - -5699,2001
FeiglGC,,BonelliCM,,BergholdA,&MokryM:Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function.J Neurosurg5 Suppl97:415- - - - - -421,2002
GanzJC,,BlacklundEO,&ThorsenFA:The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies.Stereotact Funct Neurosurg61:1 Suppl30- - - - - -37,1993
GirkinCA,,ComeyCH,,LunsfordLD,,GoodmanML,&KlineLB:Radiation optic neuropathy after stereotactic radiosurgery.Ophthalmology104:1634- - - - - -1643,1997
HayashiM,,IzawaM,,HiyamaH,,NakamuraS,,AtsuchiS,&SatoH,et al.:Gamma knife radiosurgery for pituitary adenomas.Stereotact Funct Neurosurg72:1 Suppl111- - - - - -118,1999
HoybyeC,,GrenbackE,,RahnT,,DegerbladM,,ThorenM,&HultingAL:Adrenocortcotrophic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery.开云体育app官方网站下载入口49:284- - - - - -292,2001
IzawaM,,HayashiM,,NakayaK,,SatohH,,OchiaiT,&HoriT,et al.:Gamma knife radiosurgery for pituitary adenomas.J Neurosurg93:3 Suppl19- - - - - -22,2000
KimSH,,HuhR,,ChangJW,,ParkYG,&ChungSS:Gamma knife radiosurgery for functioning pituitary adenomas.Stereotact Funct Neurosurg72:1 Suppl101- - - - - -110,1999
KobayashiT,,KidaY,&MoriY:Gamma knife radiosurgery in the treatment of Cushing disease: long-term results.J Neurosurg97:5 Suppl422- - - - - -428,2002
LandoltAM,,HallerD,,LomaxN,,ScheibS,,SchubigerO,&SiegfriedJ,et al.:Octreotide may act as a radioprotective agent in acromegaly.J Clin Endocrinol Metab85:1287- - - - - -1289,2000
LawsER,,VanceML,&ThaparK:Pituitary surgery for the management of acromegaly.Horm Res53:3 Suppl71- - - - - -75,2000
LawsERJr,,FodeNC,&RedmondMJ:Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients.J Neurosurg63:823- - - - - -829,1985
LeberKA,,BergloffJ,,LangmannG,,MokryM,,SchrottnerO,&PendlG:Radiation sensitivity of visual and oculomotor pathways.Stereotact Funct Neurosurg64:1 Suppl233- - - - - -238,1995
LeksellL:Stereotaxis and Radiosurgery: An Operative SystemSpringfield, IL,Charles C Thomas,1971
LevyRP,,FabrikantJI,,FrankelKA,,PhillipsMH,,LymanJT,&LawrenceJH,et al.:Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients.Stereotact Funct Neurosurg57:22- - - - - -35,1991
OveR,,KelmanS,,AminPP,&ChinLS:Preservation of visual fields after perisellar gamma knife radiosurgery.Int J Cancer90:343- - - - - -350,2000
PollockBE,,KondziolkaD,,LunsfordLD,&FlickingerJC:Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results.Acta Neurochir Suppl62:33- - - - - -38,1994
PollockBE,,NippoldtTB,,StaffordSL,,FooteRL,&AbboudCF:Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization.J Neurosurg97:525- - - - - -530,2002
RahnT,,ThorenM,&WernerS,Stereotactic radiosurgery in pituitary adenomas.FagliaG,,Beck-PeccozP,,AmbrosiB,,TravagliniP,&SpadaA:Pituitary Adenomas: New Trends in Basic and Clinical ResearchNew York,Excerpta Medica,1991.303- - - - - -312
ReitmeyerM,,VanceML,&LawsERJr:The neurosurgical management of Cushing's disease.Mol Cell Endocrinol197:73- - - - - -79,2002
SalingerDJ,,BradyLW,&MiyamotoCT:Radiation therapy in the treatment of pituitary adenomas.Am J Clin Oncol15:467- - - - - -473,1992
SeoY,,FukuokaS,,TakanashiM,,SasakiT,,SuematsuK,&NakamuraJ:Gamma knife surgery for Cushing's disease.Surg Neurol43:170- - - - - -176,1995
SheehanJM,,LopesMB,,SheehanJP,,EllegalaD,,WebbKM,&LawsERJr:Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor.开云体育app官方网站下载入口47:33- - - - - -39,2000
SheehanJM,,VanceML,,SheehanJP,,EllegalaDB,&LawsERJr:Radiosurgery for Cushing's disease after failed transsphenoidal surgery.J Neurosurg93:738- - - - - -742,2000
ShinM,,KuritaH,,SasakiT,,TagoM,,MoritaA,&UekiK,et al.:立体定向放射治疗的垂体腺瘤vading the cavernous sinus.J Neurosurg93:3 Suppl2- - - - - -5,2000
SimmonsNE,&LawsERJr:Glioma occurrence after sellar irradiation: case report and review.开云体育app官方网站下载入口42:172- - - - - -178,1998
StaffordSL,,PollockBE,,LeavittJA,,FooteRL,,BrownPD,&LinkMJ,et al.:A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery.Int J Radiat Oncol Biol Phys55:1177- - - - - -1181,2003
TishlerRB,,LoefflerJS,,LunsfordLD,,DumaC,,AlexanderEIII,&KooyHM,et al.:Tolerance of cranial nerves of the cavernous sinus to radiosurgery.Int J Radiat Oncol Biol Phys27:215- - - - - -221,1993
WittTC,,KondziolkaD,,FlickingerJC,&LunsfordLD,Stereotactic radiosurgery for pituitary tumors.KondziolkaD:Radiosurgery1995.Basel,Karger,1996.1:55- - - - - -65
YoonSC,,SuhTS,,JangHS,,ChungSM,,KimYS,&RyuMR,et al.:Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery.Int J Radiat Onc Biol Phys41:849- - - - - -853,1998
ZhangN,,PanL,,WangEM,,DaiJZ,,WangBJ,&CaiPW:Radiosurgery for growth hormone-producing pituitary adenomas.J Neurosurg93:3 Suppl6- - - - - -9,2000
ZierhutD,,FlentjeM,,AdolphJ,,ErdmannJ,,RaueF,&WannenmacherM:External radiotherapy of pituitary adenomas.Int J Radiat Oncol Biol Phys33:307- - - - - -314,1995
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 3153 | 1225 | 55 |
Full Text Views | 273 | 14 | 1 |
PDF Downloads | 138 | 8 | 1 |
EPUB Downloads | 0 | 0 | 0 |